With next-generation sequencing becoming faster and more cost-effective, more and more biopharma companies are looking to capitalize on this innovative technology. NGS data can be used to optimize everything from host cell line engineering and selection to assessing production samples for adventitious agents such as viruses, bacteria, and fungi. Genedata Selector® for Biopharma, is an enterprise software platform that enables scientists to integrate, manage, and analyze genomic data, metabolic pathways, phenotypes, and intellectual property on a single platform. Based on sophisticated data analysis algorithms, Genedata Selector supports efficient NGS based cell line design and selection and precise gene editing for any organism or genome of interest (both for de novo or resequencing projects).
Our solution portfolio consists of scientific and technical consulting. Genedata scientific consulting addresses the complete life cycle of biopharmaceutical R&D projects – from early-stage feasibility studies through late-stage product development – delivering a full portfolio of analysis and bioinformatics services. Our broad spectrum of technical consulting services ranges from custom software development, strategic co-development projects, and data loading/integration to hosting and IT services.